Related Experiment Video
Updated: Jun 20, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue
Nikhil R Bhagwat1, Vera Y Roginskaya, Marie B Acquafondata
1Department of Human Genetics, University of Pittsburgh School of Public Health, PA, USA.
Abstract:
The high incidence of resistance to DNA-damaging chemotherapeutic drugs and severe side effects of chemotherapy have led to a search for biomarkers able to predict which patients are most likely to respond to therapy. ERCC1-XPF nuclease is required for nucleotide excision repair of helix-distorting DNA damage and the repair of DNA interstrand crosslinks. Thus, it is essential for several pathways of repair of DNA damage by cisplatin and related drugs, which are widely used in the treatment of non-small cell lung carcinoma and other late-stage tumors. Consequently, there is tremendous interest in measuring ERCC1-XPF expression in tumor samples. Many immunohistochemistry studies have been done, but the antibodies for ERCC1-XPF were not rigorously tested for antigen specificity. Herein, we survey a battery of antibodies raised against human ERCC1 or XPF for their specificity using ERCC1-XPF-deficient cells as a negative control. Antibodies were tested for the following applications: immunoblotting, immunoprecipitation from cell extracts, immunofluorescence detection in fixed cells, colocalization of ERCC1-XPF with UV radiation-induced DNA damage in fixed cells, and immunohistochemistry in paraffin-embedded samples. Although several commercially available antibodies are suitable for immunodetection of ERCC1-XPF in some applications, only a select subset is appropriate for detection of this repair complex in fixed specimens. The most commonly used antibody, 8F1, is not suitable for immunodetection in tissue. The results with validated antibodies reveal marked differences in ERCC1-XPF protein levels between samples and cell types.
Insights
Accurate measurement of ERCC1-XPF protein is crucial for predicting chemotherapy response. This study validates antibodies for detecting ERCC1-XPF, finding many commonly used ones are unsuitable for tissue analysis.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Chemotherapy resistance and side effects necessitate predictive biomarkers.
- ERCC1-XPF nuclease is vital for DNA repair pathways targeted by cisplatin-based chemotherapy.
- Accurate ERCC1-XPF expression measurement in tumors is critical for personalized cancer treatment.
Purpose of the Study:
- To rigorously evaluate the specificity of various antibodies against human ERCC1 or XPF.
- To identify reliable antibodies for detecting ERCC1-XPF protein in different biological samples and applications.
- To assess the suitability of antibodies for detecting ERCC1-XPF in fixed specimens for clinical relevance.
Main Methods:
- Tested a panel of antibodies against ERCC1-XPF using ERCC1-XPF-deficient cells as a negative control.
- Evaluated antibody specificity across multiple applications: immunoblotting, immunoprecipitation, immunofluorescence, and immunohistochemistry.
- Assessed antibody performance in detecting ERCC1-XPF colocalization with UV-induced DNA damage in fixed cells.
Main Results:
- Several antibodies demonstrated suitability for ERCC1-XPF immunodetection in specific applications.
- The widely used 8F1 antibody was found unsuitable for immunodetection in tissue samples.
- Validated antibodies revealed significant variations in ERCC1-XPF protein levels across different cell types and samples.
Conclusions:
- Only a subset of commercially available antibodies are appropriate for reliable ERCC1-XPF detection in fixed specimens.
- Validated antibodies are essential for accurate assessment of ERCC1-XPF expression as a predictive biomarker.
- This study provides critical guidance for selecting appropriate antibodies for ERCC1-XPF research and clinical applications.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Nucleotide Excision Repair
Long-patch Base Excision Repair
Base Excision Repair
The first step of...
Overview of DNA Repair
Chemically...

